We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
1151
Viatris
VTRS
$20.8B
$259K ﹤0.01%
22,349
+1,794
+9% +$20.7K
CZR icon
1152
Caesars Entertainment
CZR
$6.06B
$258K ﹤0.01%
+6,184
New +$232K
FMNB icon
1153
Farmers National Banc Corp
FMNB
$944M
$257K ﹤0.01%
17,000
– –
LDOS icon
1154
Leidos
LDOS
$14.6B
$257K ﹤0.01%
1,576
-36
-2% -$5.45K
KRE icon
1155
State Street SPDR S&P Regional Banking ETF
KRE
$4.52B
$256K ﹤0.01%
4,525
-510
-10% -$28K
MRCY icon
1156
Mercury Systems
MRCY
$5.52B
$256K ﹤0.01%
+6,916
New +$243K
BCS icon
1157
Barclays
BCS
$88.5B
$256K ﹤0.01%
21,044
+1,420
+7% +$16.6K
BMRN icon
1158
BioMarin Pharmaceuticals
BMRN
$12B
$254K ﹤0.01%
+3,614
New +$302K
FICO icon
1159
Fair Isaac
FICO
$32B
$253K ﹤0.01%
+130
New +$222K
BBCA icon
1160
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
$250K ﹤0.01%
3,464
– –
RUN icon
1161
Sunrun
RUN
$2.27B
$250K ﹤0.01%
13,851
+7
+0.1% +$124
INDY icon
1162
iShares S&P India Nifty 50 Index Fund
INDY
$558M
$250K ﹤0.01%
4,443
– –
VEEV icon
1163
Veeva Systems
VEEV
$33.6B
$246K ﹤0.01%
1,173
-33
-3% -$6.52K
WTS icon
1164
Watts Water Technologies
WTS
$11.3B
$246K ﹤0.01%
+1,186
New +$229K
IDU icon
1165
iShares US Utilities ETF
IDU
$1.39B
$245K ﹤0.01%
+2,400
New +$227K
REG icon
1166
Regency Centers
REG
$14.9B
$244K ﹤0.01%
3,382
+141
+4% +$9.76K
DUOL icon
1167
Duolingo
DUOL
$6.49B
$243K ﹤0.01%
+861
New +$177K
FTRE icon
1168
Fortrea Holdings
FTRE
$1.95B
$243K ﹤0.01%
12,138
-13,626
-53% -$320K
WIT icon
1169
Wipro
WIT
$19.3B
$242K ﹤0.01%
74,654
+3,492
+5% +$10.9K
JHX icon
1170
James Hardie Industries
JHX
$15.3B
$242K ﹤0.01%
+6,017
New +$211K
MOO icon
1171
VanEck Agribusiness ETF
MOO
$993M
$241K ﹤0.01%
3,191
– –
NOK icon
1172
Nokia
NOK
$47.8B
$241K ﹤0.01%
55,043
+10,179
+23% +$41.2K
PRAX icon
1173
Praxis Precision Medicines
PRAX
$8.14B
$240K ﹤0.01%
+4,173
New +$225K
WDC icon
1174
Western Digital
WDC
$159B
$240K ﹤0.01%
4,648
-1,537
-25% -$77.7K
APA icon
1175
APA Corp
APA
$12.8B
$240K ﹤0.01%
9,803
+775
+9% +$21.8K
45 46
47
48 49

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.